Article Name Clinical Trials and Research
The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial
02nd September, 2025
Revenue up 5.8 per cent to HK$876.5 million, Profit up 3.8 per cent to HK$163.4 million
01st September, 2025
The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care.
01st September, 2025
Lumipulse pTau-217/Beta Amyloid 42 ratio now available nationwide through Labcorp
19th August, 2025
Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device.
14th August, 2025
Trial to assess Calibreye™ Titratable Glaucoma Therapy™ Surgical System in refractory glaucoma patients
13th August, 2025
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer